PuSH - Publication Server of Helmholtz Zentrum München

Zaghlool, S.B.* ; Mook-Kanamori, D.O.* ; Kader, S.* ; Stephan, N.* ; Halama, A.* ; Engelke, R.* ; Sarwath, H.* ; Al-Dous, E.K.* ; Mohamoud, Y.A.* ; Römisch-Margl, W. ; Adamski, J. ; Kastenmüller, G. ; Friedrich, N.* ; Visconti, A.* ; Tsai, P.C.* ; Spector, T.* ; Bell, J.* ; Falchi, M.* ; Wahl, A. ; Waldenberger, M. ; Peters, A. ; Gieger, C. ; Pezer, M.* ; Lauc, G.* ; Graumann, J.* ; Malek, J.A.* ; Suhre, K.*

Deep molecular phenotypes link complex disorders and physiological insult to CpG methylation.

Hum. Mol. Genet. 27, 1106-1121 (2018)
Publ. Version/Full Text Postprint Research data DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Epigenetic regulation of cellular function provides a mechanism for rapid organismal adaptation to changes in health, lifestyle and environment. Associations of cytosine-guanine di-nucleotide (CpG) methylation with clinical endpoints that overlap with metabolic phenotypes suggest a regulatory role for these CpG sites in the body's response to disease or environmental stress. We previously identified 20 CpG sites in an epigenome-wide association study (EWAS) with metabolomics that were also associated in recent EWASs with diabetes-, obesity-, and smoking-related endpoints. To elucidate the molecular pathways that connect these potentially regulatory CpG sites to the associated disease or lifestyle factors, we conducted a multi-omics association study including 2474 mass-spectrometry-based metabolites in plasma, urine and saliva, 225 NMR-based lipid and metabolite measures in blood, 1124 blood-circulating proteins using aptamer technology, 113 plasma protein N-glycans and 60 IgG-glyans, using 359 samples from the multi-ethnic Qatar Metabolomics Study on Diabetes (QMDiab). We report 138 multi-omics associations at these CpG sites, including diabetes biomarkers at the diabetes-associated TXNIP locus, and smoking-specific metabolites and proteins at multiple smoking-associated loci, including AHRR. Mendelian randomization suggests a causal effect of metabolite levels on methylation of obesity-associated CpG sites, i.e. of glycerophospholipid PC(O-36: 5), glycine and a very low-density lipoprotein (VLDL-A) on the methylation of the obesity-associated CpG loci DHCR24, MYO5C and CPT1A, respectively. Taken together, our study suggests that multi-omics-associated CpG methylation can provide functional read-outs for the underlying regulatory response mechanisms to disease or environmental insults.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
4.902
1.226
16
21
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Mendelian Randomization ; Glycomics ; Lipidomics ; Metabolomics ; Methylation ; Multi-omics ; Proteomics; Epigenome-wide Association; Body-mass Index; Differential Dna Methylation; Self-reported Smoking; Mendelian Randomization; Biomarker Discovery; Tobacco-smoking; Down-regulation; Serum Cotinine; Human Plasma
Language english
Publication Year 2018
HGF-reported in Year 2018
ISSN (print) / ISBN 0964-6906
e-ISSN 1460-2083
Quellenangaben Volume: 27, Issue: 6, Pages: 1106-1121 Article Number: , Supplement: ,
Publisher Oxford University Press
Publishing Place Oxford
Reviewing status Peer reviewed
POF-Topic(s) 30505 - New Technologies for Biomedical Discoveries
30201 - Metabolic Health
30202 - Environmental Health
Research field(s) Enabling and Novel Technologies
Genetics and Epidemiology
PSP Element(s) G-503700-001
G-500600-001
G-504091-001
G-504000-001
Scopus ID 85043335574
PubMed ID 29325019
Erfassungsdatum 2018-03-09